Zevra Therapeutics (ZVRA) Shares Outstanding (2014 - 2026)
Zevra Therapeutics' Weighted Average Shares Outstanding was 59.41 million in Q3 2026, up 6.2% from 55.95 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Shares Outstanding (2014 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding at Zevra Therapeutics came in at 55.31 million, up 19.6% from FY2024.
- Weighted Average Shares Outstanding has now increased for three consecutive years, with a five-year compound annual growth rate of 47.4% (FY2020 to FY2025).
- In earlier years, Weighted Average Shares Outstanding was 46.25 million in FY2024 (+30.5%), 35.45 million in FY2023 (+2.8%), 34.49 million in FY2022 (-42.1%) and 59.53 million in FY2021 (+647.7%).
- The Q3 2026 figure marks the highest quarterly Weighted Average Shares Outstanding since Q3 2022.
- Compared with a year earlier, Weighted Average Shares Outstanding has increased for 12 straight quarters, with growth averaging 18.7% over the last eight quarters.
- The best year-over-year quarter for Weighted Average Shares Outstanding over five years was Q4 2021 (growth of 647.7%); the worst was Q2 2023 (a decline of 50.8%).
- Per Business Quant data, ZVRA's Weighted Average Shares Outstanding in the three quarters before Q3 2026 was 59.16 million (Q2 2026), 58.41 million (Q1 2026) and 55.31 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.94 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.55 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 59.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 59.41 Mn |
| Jun 30, 2026 | 59.16 Mn |
| Mar 31, 2026 | 58.41 Mn |
| Dec 31, 2025 | 55.31 Mn |
| Sep 30, 2025 | 55.95 Mn |
| Jun 30, 2025 | 54.78 Mn |
| Mar 31, 2025 | 54.10 Mn |
| Dec 31, 2024 | 46.25 Mn |
| Sep 30, 2024 | 47.81 Mn |
| Jun 30, 2024 | 41.90 Mn |
| Mar 31, 2024 | 41.78 Mn |
| Dec 31, 2023 | 35.45 Mn |
| Sep 30, 2023 | 34.73 Mn |
| Jun 30, 2023 | 33.90 Mn |
| Mar 31, 2023 | 34.47 Mn |
| Dec 31, 2022 | 34.49 Mn |
| Sep 30, 2022 | 68.99 Mn |
| Jun 30, 2022 | 68.89 Mn |
| Mar 31, 2022 | 69.01 Mn |
| Dec 31, 2021 | 59.53 Mn |
API Access
Zevra Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();